Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Weitz

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Hepatology Communications|April 21, 2025
Health economic outcomes of a minimal monitoring approach to providing HCV therapyBenjamin P Linas, Michelle Weitz, Tannishtha Pramanick, et al.
Plos One|March 27, 2025
Empirical calibration of a simulation model of opioid use disorderR W M A Madushani, Jianing Wang, Michelle Weitz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 10, 2022
Impact of Genetic Counseling on Patient-Reported Electronic Cancer Family History CollectionRebecca A Vanderwall, Alison Schwartz, Lindsay Kipnis, et al.
JAMA Network Open|April 14, 2023
Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in MassachusettsAvik Chatterjee, Michelle Weitz, Alexandra Savinkina, et al.
The Journal of School Health|March 7, 2022
Resources Required for Implementation of SARS-CoV-2 Screening in Massachusetts K-12 Public Schools in Winter/Spring 2021Stephanie S Lee, Michelle Weitz, Kristin Ardlie, et al.
JCO Oncology Practice|April 10, 2025
Video Education Is an Acceptable Alternative to Pretest Genetic Counseling for Patients With Breast, Ovarian, Pancreatic, and Metastatic Prostate Cancer: Results From a Randomized StudyKatherine A Schneider, Lauren Massingham, Michelle Weitz, et al.
Journal of the National Cancer Institute|May 22, 2024
Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer (ECOG-ACRIN E7208)Howard S Hochster, Paul Catalano, Michelle Weitz, et al.
JAMA Network Open|September 13, 2023
Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use DisorderJuliet M Flam-Ross, Elizabeth Marsh, Michelle Weitz, et al.
NPJ Breast Cancer|November 14, 2024
Performance of an AI-powered visualization software platform for precision surgery in breast cancer patientsMichelle Weitz, J R Pfeiffer, Snehal Patel, et al.
Breast Cancer Research : BCR|December 1, 2020
Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastasesJose Pablo Leone, Kyrre E Emblem, Michelle Weitz, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Hepatology Communications|April 21, 2025
Health economic outcomes of a minimal monitoring approach to providing HCV therapyBenjamin P Linas, Michelle Weitz, Tannishtha Pramanick, et al.
Plos One|March 27, 2025
Empirical calibration of a simulation model of opioid use disorderR W M A Madushani, Jianing Wang, Michelle Weitz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 10, 2022
Impact of Genetic Counseling on Patient-Reported Electronic Cancer Family History CollectionRebecca A Vanderwall, Alison Schwartz, Lindsay Kipnis, et al.
JAMA Network Open|April 14, 2023
Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in MassachusettsAvik Chatterjee, Michelle Weitz, Alexandra Savinkina, et al.
The Journal of School Health|March 7, 2022
Resources Required for Implementation of SARS-CoV-2 Screening in Massachusetts K-12 Public Schools in Winter/Spring 2021Stephanie S Lee, Michelle Weitz, Kristin Ardlie, et al.
JCO Oncology Practice|April 10, 2025
Video Education Is an Acceptable Alternative to Pretest Genetic Counseling for Patients With Breast, Ovarian, Pancreatic, and Metastatic Prostate Cancer: Results From a Randomized StudyKatherine A Schneider, Lauren Massingham, Michelle Weitz, et al.
Journal of the National Cancer Institute|May 22, 2024
Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer (ECOG-ACRIN E7208)Howard S Hochster, Paul Catalano, Michelle Weitz, et al.
JAMA Network Open|September 13, 2023
Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use DisorderJuliet M Flam-Ross, Elizabeth Marsh, Michelle Weitz, et al.
NPJ Breast Cancer|November 14, 2024
Performance of an AI-powered visualization software platform for precision surgery in breast cancer patientsMichelle Weitz, J R Pfeiffer, Snehal Patel, et al.
Breast Cancer Research : BCR|December 1, 2020
Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastasesJose Pablo Leone, Kyrre E Emblem, Michelle Weitz, et al.
Pageof 2